Type |
Details |
Score |
Gene |
Type: |
gene |
Organism: |
human |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
chimpanzee |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
cattle |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
chicken |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
zebrafish |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
macaque, rhesus |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
frog, western clawed |
|
•
•
•
•
•
|
Gene |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
dog, domestic |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
946
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Publication |
First Author: |
Li Y |
Year: |
2019 |
Journal: |
Endocrinology |
Title: |
Mice Missing Cnr1 and Cnr2 Show Implantation Defects. |
Volume: |
160 |
Issue: |
4 |
Pages: |
938-946 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sun X |
Year: |
2014 |
Journal: |
Endocrinology |
Title: |
Cnr2 deficiency confers resistance to inflammation-induced preterm birth in mice. |
Volume: |
155 |
Issue: |
10 |
Pages: |
4006-14 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gennequin B |
Year: |
2013 |
Journal: |
Biochem Biophys Res Commun |
Title: |
CRISPR/Cas-induced double-strand breaks boost the frequency of gene replacements for humanizing the mouse Cnr2 gene. |
Volume: |
441 |
Issue: |
4 |
Pages: |
815-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sophocleous A |
Year: |
2017 |
Journal: |
Aging Cell |
Title: |
Combined deficiency of the Cnr1 and Cnr2 receptors protects against age-related bone loss by osteoclast inhibition. |
Volume: |
16 |
Issue: |
5 |
Pages: |
1051-1061 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6170071 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Absent |
Sex: |
Not Specified |
Emaps: |
EMAPS:1689419 |
|
Stage: |
TS19 |
Assay Id: |
MGI:6190000 |
Age: |
embryonic day 11.5 |
|
|
Specimen Label: |
Table S2 - E11.5 - Cnr2 |
Detected: |
false |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6170071 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Absent |
Sex: |
Not Specified |
Emaps: |
EMAPS:1689421 |
|
Stage: |
TS21 |
Assay Id: |
MGI:6190000 |
Age: |
embryonic day 13.5 |
|
|
Specimen Label: |
Table S2 - E13.5 - Cnr2 |
Detected: |
false |
Specimen Num: |
2 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6170071 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Absent |
Sex: |
Male |
Emaps: |
EMAPS:1689424 |
|
Stage: |
TS24 |
Assay Id: |
MGI:6190000 |
Age: |
embryonic day 15.5 |
|
|
Specimen Label: |
Table S2 - E15.5 - Cnr2 |
Detected: |
false |
Specimen Num: |
3 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6170071 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Absent |
Sex: |
Male |
Emaps: |
EMAPS:1689426 |
|
Stage: |
TS26 |
Assay Id: |
MGI:6190000 |
Age: |
embryonic day 18.5 |
|
|
Specimen Label: |
Table S2 - E18.5 - Cnr2 |
Detected: |
false |
Specimen Num: |
4 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6170071 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Absent |
Sex: |
Male |
Emaps: |
EMAPS:1689428 |
|
Stage: |
TS28 |
Assay Id: |
MGI:6190000 |
Age: |
postnatal day 4 |
|
|
Specimen Label: |
Table S2 - P4 - Cnr2 |
Detected: |
false |
Specimen Num: |
5 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6170071 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Absent |
Sex: |
Male |
Emaps: |
EMAPS:1689428 |
|
Stage: |
TS28 |
Assay Id: |
MGI:6190000 |
Age: |
postnatal day 14 |
|
|
Specimen Label: |
Table S2 - P14 - Cnr2 |
Detected: |
false |
Specimen Num: |
6 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6170071 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Absent |
Sex: |
Male |
Emaps: |
EMAPS:1689428 |
|
Stage: |
TS28 |
Assay Id: |
MGI:6190000 |
Age: |
postnatal day 28 |
|
|
Specimen Label: |
Table S2 - P28 - Cnr2 |
Detected: |
false |
Specimen Num: |
7 |
|
•
•
•
•
•
|
Publication |
First Author: |
López A |
Year: |
2018 |
Journal: |
J Neuroinflammation |
Title: |
Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer's disease. |
Volume: |
15 |
Issue: |
1 |
Pages: |
158 |
|
•
•
•
•
•
|
Publication |
First Author: |
Borowska-Fielding J |
Year: |
2018 |
Journal: |
Neuropharmacology |
Title: |
Revisiting cannabinoid receptor 2 expression and function in murine retina. |
Volume: |
141 |
|
Pages: |
21-31 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yuan CY |
Year: |
2021 |
Journal: |
Blood |
Title: |
Signaling through the type 2 cannabinoid receptor regulates the severity of acute and chronic graft-versus-host disease. |
Volume: |
137 |
Issue: |
9 |
Pages: |
1241-1255 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lin X |
Year: |
2022 |
Journal: |
Pain |
Title: |
A peripheral CB2 cannabinoid receptor mechanism suppresses chemotherapy-induced peripheral neuropathy: evidence from a CB2 reporter mouse. |
Volume: |
163 |
Issue: |
5 |
Pages: |
834-851 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
targeted mutation, mutant strain, congenic |
|
•
•
•
•
•
|
Publication |
First Author: |
Liu QR |
Year: |
2017 |
Journal: |
Sci Rep |
Title: |
Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference. |
Volume: |
7 |
Issue: |
1 |
Pages: |
17410 |
|
•
•
•
•
•
|
Publication |
First Author: |
Duff G |
Year: |
2013 |
Journal: |
PLoS One |
Title: |
Cannabinoid receptor CB2 modulates axon guidance. |
Volume: |
8 |
Issue: |
8 |
Pages: |
e70849 |
|
•
•
•
•
•
|
Publication |
First Author: |
Desroches J |
Year: |
2014 |
Journal: |
Neuroscience |
Title: |
Involvement of cannabinoid receptors in peripheral and spinal morphine analgesia. |
Volume: |
261 |
|
Pages: |
23-42 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cécyre B |
Year: |
2020 |
Journal: |
Sci Rep |
Title: |
Cannabinoids affect the mouse visual acuity via the cannabinoid receptor type 2. |
Volume: |
10 |
Issue: |
1 |
Pages: |
15819 |
|
•
•
•
•
•
|
Publication |
First Author: |
Alferink J |
Year: |
2016 |
Journal: |
J Biol Chem |
Title: |
Cannabinoid Receptor 2 Modulates Susceptibility to Experimental Cerebral Malaria through a CCL17-dependent Mechanism. |
Volume: |
291 |
Issue: |
37 |
Pages: |
19517-31 |
|
•
•
•
•
•
|
Publication |
First Author: |
Iden JA |
Year: |
2023 |
Journal: |
Int J Mol Sci |
Title: |
The Anti-Tumorigenic Role of Cannabinoid Receptor 2 in Colon Cancer: A Study in Mice and Humans. |
Volume: |
24 |
Issue: |
4 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Deveaux V |
Year: |
2009 |
Journal: |
PLoS One |
Title: |
Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis. |
Volume: |
4 |
Issue: |
6 |
Pages: |
e5844 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shapiro L |
Year: |
2019 |
Journal: |
Epilepsia |
Title: |
Reduced cannabinoid 2 receptor activity increases susceptibility to induced seizures in mice. |
Volume: |
60 |
Issue: |
12 |
Pages: |
2359-2369 |
|
•
•
•
•
•
|
Publication |
First Author: |
Valk PJ |
Year: |
1997 |
Journal: |
J Virol |
Title: |
The genes encoding the peripheral cannabinoid receptor and alpha-L-fucosidase are located near a newly identified common virus integration site, Evi11. |
Volume: |
71 |
Issue: |
9 |
Pages: |
6796-804 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang H |
Year: |
2008 |
Journal: |
PLoS One |
Title: |
Loss of cannabinoid receptor CB1 induces preterm birth. |
Volume: |
3 |
Issue: |
10 |
Pages: |
e3320 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sisay S |
Year: |
2013 |
Journal: |
PLoS One |
Title: |
Genetic background can result in a marked or minimal effect of gene knockout (GPR55 and CB2 receptor) in experimental autoimmune encephalomyelitis models of multiple sclerosis. |
Volume: |
8 |
Issue: |
10 |
Pages: |
e76907 |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus caroli |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus pahari |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus spretus |
|
•
•
•
•
•
|
Publication |
First Author: |
Shire D |
Year: |
1996 |
Journal: |
Biochim Biophys Acta |
Title: |
Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor. |
Volume: |
1307 |
Issue: |
2 |
Pages: |
132-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Buckley NE |
Year: |
2000 |
Journal: |
Eur J Pharmacol |
Title: |
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. |
Volume: |
396 |
Issue: |
2-3 |
Pages: |
141-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ziring D |
Year: |
2006 |
Journal: |
Immunogenetics |
Title: |
Formation of B and T cell subsets require the cannabinoid receptor CB2. |
Volume: |
58 |
Issue: |
9 |
Pages: |
714-25 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ofek O |
Year: |
2006 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Peripheral cannabinoid receptor, CB2, regulates bone mass. |
Volume: |
103 |
Issue: |
3 |
Pages: |
696-701 |
|
•
•
•
•
•
|
Publication |
First Author: |
Munro S |
Year: |
1993 |
Journal: |
Nature |
Title: |
Molecular characterization of a peripheral receptor for cannabinoids. |
Volume: |
365 |
Issue: |
6441 |
Pages: |
61-5 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pérez-Gómez E |
Year: |
2015 |
Journal: |
J Natl Cancer Inst |
Title: |
Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer. |
Volume: |
107 |
Issue: |
6 |
Pages: |
djv077 |
|
•
•
•
•
•
|
Publication |
First Author: |
Stempel AV |
Year: |
2016 |
Journal: |
Neuron |
Title: |
Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus. |
Volume: |
90 |
Issue: |
4 |
Pages: |
795-809 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bouchard J |
Year: |
2012 |
Journal: |
J Neurosci |
Title: |
Cannabinoid receptor 2 signaling in peripheral immune cells modulates disease onset and severity in mouse models of Huntington's disease. |
Volume: |
32 |
Issue: |
50 |
Pages: |
18259-68 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kong W |
Year: |
2014 |
Journal: |
Cell Immunol |
Title: |
Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS. |
Volume: |
287 |
Issue: |
1 |
Pages: |
1-17 |
|
•
•
•
•
•
|
Publication |
First Author: |
Schmöle AC |
Year: |
2015 |
Journal: |
Neurobiol Aging |
Title: |
Cannabinoid receptor 2 deficiency results in reduced neuroinflammation in an Alzheimer's disease mouse model. |
Volume: |
36 |
Issue: |
2 |
Pages: |
710-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wotherspoon G |
Year: |
2005 |
Journal: |
Neuroscience |
Title: |
Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons. |
Volume: |
135 |
Issue: |
1 |
Pages: |
235-45 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sadanandan SM |
Year: |
2020 |
Journal: |
PLoS One |
Title: |
Cannabinoid type 2 receptors inhibit GABAA receptor-mediated currents in cerebellar Purkinje cells of juvenile mice. |
Volume: |
15 |
Issue: |
5 |
Pages: |
e0233020 |
|
•
•
•
•
•
|
Publication |
First Author: |
Barutta F |
Year: |
2011 |
Journal: |
Diabetes |
Title: |
Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy. |
Volume: |
60 |
Issue: |
9 |
Pages: |
2386-96 |
|
•
•
•
•
•
|
Publication |
First Author: |
Amenta PS |
Year: |
2014 |
Journal: |
J Neuroinflammation |
Title: |
Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury. |
Volume: |
11 |
|
Pages: |
191 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rom S |
Year: |
2013 |
Journal: |
Am J Pathol |
Title: |
Selective activation of cannabinoid receptor 2 in leukocytes suppresses their engagement of the brain endothelium and protects the blood-brain barrier. |
Volume: |
183 |
Issue: |
5 |
Pages: |
1548-58 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hu Y |
Year: |
2019 |
Journal: |
Biosci Rep |
Title: |
Cannabinoid receptor 2 deletion deteriorates myocardial infarction through the down-regulation of AMPK-mTOR-p70S6K signaling-mediated autophagy. |
Volume: |
39 |
Issue: |
4 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Ramirez SH |
Year: |
2012 |
Journal: |
J Neurosci |
Title: |
Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions. |
Volume: |
32 |
Issue: |
12 |
Pages: |
4004-16 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tschöp J |
Year: |
2009 |
Journal: |
J Immunol |
Title: |
The cannabinoid receptor 2 is critical for the host response to sepsis. |
Volume: |
183 |
Issue: |
1 |
Pages: |
499-505 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ke P |
Year: |
2016 |
Journal: |
PLoS One |
Title: |
Activation of Cannabinoid Receptor 2 Ameliorates DSS-Induced Colitis through Inhibiting NLRP3 Inflammasome in Macrophages. |
Volume: |
11 |
Issue: |
9 |
Pages: |
e0155076 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shao BZ |
Year: |
2014 |
Journal: |
CNS Neurosci Ther |
Title: |
Activating cannabinoid receptor 2 alleviates pathogenesis of experimental autoimmune encephalomyelitis via activation of autophagy and inhibiting NLRP3 inflammasome. |
Volume: |
20 |
Issue: |
12 |
Pages: |
1021-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kapellos TS |
Year: |
2019 |
Journal: |
FASEB J |
Title: |
Cannabinoid receptor 2 deficiency exacerbates inflammation and neutrophil recruitment. |
Volume: |
33 |
Issue: |
5 |
Pages: |
6154-6167 |
|
•
•
•
•
•
|
Publication |
First Author: |
Willecke F |
Year: |
2011 |
Journal: |
PLoS One |
Title: |
Cannabinoid receptor 2 signaling does not modulate atherogenesis in mice. |
Volume: |
6 |
Issue: |
4 |
Pages: |
e19405 |
|
•
•
•
•
•
|
Publication |
First Author: |
den Boon FS |
Year: |
2012 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors. |
Volume: |
109 |
Issue: |
9 |
Pages: |
3534-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Toguri JT |
Year: |
2018 |
Journal: |
Prostaglandins Other Lipid Mediat |
Title: |
Inflammation and CB2 signaling drive novel changes in the ocular lipidome and regulate immune cell activity in the eye. |
Volume: |
139 |
|
Pages: |
54-62 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mensching L |
Year: |
2019 |
Journal: |
Int J Mol Sci |
Title: |
Stable Adult Hippocampal Neurogenesis in Cannabinoid Receptor CB2 Deficient Mice. |
Volume: |
20 |
Issue: |
15 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Barutta F |
Year: |
2014 |
Journal: |
Kidney Int |
Title: |
Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice. |
Volume: |
86 |
Issue: |
5 |
Pages: |
979-90 |
|
•
•
•
•
•
|
Publication |
First Author: |
Burston JJ |
Year: |
2013 |
Journal: |
PLoS One |
Title: |
Cannabinoid CB2 receptors regulate central sensitization and pain responses associated with osteoarthritis of the knee joint. |
Volume: |
8 |
Issue: |
11 |
Pages: |
e80440 |
|
•
•
•
•
•
|
Publication |
First Author: |
Taylor L |
Year: |
2015 |
Journal: |
Sci Rep |
Title: |
Primary Macrophage Chemotaxis Induced by Cannabinoid Receptor 2 Agonists Occurs Independently of the CB2 Receptor. |
Volume: |
5 |
|
Pages: |
10682 |
|
•
•
•
•
•
|
Publication |
First Author: |
Feng L |
Year: |
2023 |
Journal: |
Exp Neurol |
Title: |
Loss of cannabinoid receptor 2 promotes α-Synuclein-induced microglial synaptic pruning in nucleus accumbens by modulating the pCREB-c-Fos signaling pathway and complement system. |
Volume: |
359 |
|
Pages: |
114230 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kibret BG |
Year: |
2023 |
Journal: |
Behav Brain Res |
Title: |
Cannabinoid CB2 receptors modulate alcohol induced behavior, and neuro-immune dysregulation in mice. |
Volume: |
448 |
|
Pages: |
114439 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bátkai S |
Year: |
2007 |
Journal: |
FASEB J |
Title: |
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury. |
Volume: |
21 |
Issue: |
8 |
Pages: |
1788-800 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nozaki C |
Year: |
2018 |
Journal: |
Sci Rep |
Title: |
Involvement of leptin signaling in the development of cannabinoid CB2 receptor-dependent mirror image pain. |
Volume: |
8 |
Issue: |
1 |
Pages: |
10827 |
|
•
•
•
•
•
|
Publication |
First Author: |
Thewke D |
Year: |
2009 |
Journal: |
Biochem Biophys Res Commun |
Title: |
AM-251 and SR144528 are acyl CoA:cholesterol acyltransferase inhibitors. |
Volume: |
381 |
Issue: |
2 |
Pages: |
181-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li X |
Year: |
2023 |
Journal: |
Nat Commun |
Title: |
Structural basis of selective cannabinoid CB(2) receptor activation. |
Volume: |
14 |
Issue: |
1 |
Pages: |
1447 |
|
•
•
•
•
•
|
Publication |
First Author: |
GarcÃa-Gutiérrez MS |
Year: |
2013 |
Journal: |
Neuropharmacology |
Title: |
Synaptic plasticity alterations associated with memory impairment induced by deletion of CB2 cannabinoid receptors. |
Volume: |
73 |
|
Pages: |
388-96 |
|
•
•
•
•
•
|
Publication |
First Author: |
Palazuelos J |
Year: |
2008 |
Journal: |
J Biol Chem |
Title: |
The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis. |
Volume: |
283 |
Issue: |
19 |
Pages: |
13320-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sophocleous A |
Year: |
2011 |
Journal: |
Endocrinology |
Title: |
The type 2 cannabinoid receptor regulates bone mass and ovariectomy-induced bone loss by affecting osteoblast differentiation and bone formation. |
Volume: |
152 |
Issue: |
6 |
Pages: |
2141-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sagredo O |
Year: |
2009 |
Journal: |
Glia |
Title: |
Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington's disease. |
Volume: |
57 |
Issue: |
11 |
Pages: |
1154-67 |
|
•
•
•
•
•
|
Publication |
First Author: |
Basu S |
Year: |
2013 |
Journal: |
PLoS One |
Title: |
Cannabinoid Receptor 2 (CB2) Plays a Role in the Generation of Germinal Center and Memory B Cells, but Not in the Production of Antigen-Specific IgG and IgM, in Response to T-dependent Antigens. |
Volume: |
8 |
Issue: |
6 |
Pages: |
e67587 |
|
•
•
•
•
•
|
Publication |
First Author: |
Olabiyi BF |
Year: |
2023 |
Journal: |
Sci Rep |
Title: |
Pharmacological blockade of cannabinoid receptor 2 signaling does not affect LPS/IFN-γ-induced microglial activation. |
Volume: |
13 |
Issue: |
1 |
Pages: |
11105 |
|
•
•
•
•
•
|
Publication |
First Author: |
Defer N |
Year: |
2009 |
Journal: |
FASEB J |
Title: |
The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy. |
Volume: |
23 |
Issue: |
7 |
Pages: |
2120-30 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ternianov A |
Year: |
2012 |
Journal: |
Neurobiol Aging |
Title: |
Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine. |
Volume: |
33 |
Issue: |
2 |
Pages: |
421.e1-16 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang ZY |
Year: |
2013 |
Journal: |
Am J Physiol Regul Integr Comp Physiol |
Title: |
Activation of cannabinoid receptor 2 inhibits experimental cystitis. |
Volume: |
304 |
Issue: |
10 |
Pages: |
R846-53 |
|
•
•
•
•
•
|